167 related articles for article (PubMed ID: 35241064)
1. Alterations in the oral microbiome of individuals with a healthy oral environment following COVID-19 vaccination.
Uehara O; Abiko Y; Nagasawa T; Morikawa T; Hiraki D; Harada F; Kawano Y; Toraya S; Matsuoka H; Paudel D; Shimizu S; Yoshida K; Asaka M; Furuichi Y; Miura H
BMC Oral Health; 2022 Mar; 22(1):50. PubMed ID: 35241064
[TBL] [Abstract][Full Text] [Related]
2. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination.
Jiao J; Shen Y; Wang P; Zuo K; Yang X; Chen M; Dong Y; Li J
Front Biosci (Landmark Ed); 2022 Oct; 27(10):280. PubMed ID: 36336856
[TBL] [Abstract][Full Text] [Related]
5. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
[TBL] [Abstract][Full Text] [Related]
6. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
7. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
Front Public Health; 2021; 9():778964. PubMed ID: 34888290
[No Abstract] [Full Text] [Related]
8. Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults.
Armstrong AJS; Horton DB; Andrews T; Greenberg P; Roy J; Gennaro ML; Carson JL; Panettieri RA; Barrett ES; Blaser MJ
EBioMedicine; 2023 Aug; 94():104731. PubMed ID: 37487417
[TBL] [Abstract][Full Text] [Related]
9. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
[TBL] [Abstract][Full Text] [Related]
10. Assessing saliva microbiome collection and processing methods.
Armstrong AJS; Parmar V; Blaser MJ
NPJ Biofilms Microbiomes; 2021 Nov; 7(1):81. PubMed ID: 34795298
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
Olariu TR; Ursoniu S; Marincu I; Lupu MA
Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
[No Abstract] [Full Text] [Related]
12. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
[TBL] [Abstract][Full Text] [Related]
13. Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
Tamura T; Ninomiya K; Kubo T; Kuyama S; Tachibana S; Inoue K; Chikamori K; Kudo K; Ochi N; Harada D; Maeda Y; Kiura K
Thorac Cancer; 2022 Feb; 13(3):453-459. PubMed ID: 34964270
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 alters human microbiomes: a meta-analysis.
Reuben RC; Beugnon R; Jurburg SD
Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
[TBL] [Abstract][Full Text] [Related]
15. Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination.
Mades A; Chellamathu P; Kojima N; Lopez L; MacMullan MA; Denny N; Angel AN; Santacruz M; Casian JG; Brobeck M; Nirema N; Klausner JD; Turner F; Slepnev VI; Ibrayeva A
Sci Rep; 2021 Dec; 11(1):24448. PubMed ID: 34961780
[TBL] [Abstract][Full Text] [Related]
16. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722
[TBL] [Abstract][Full Text] [Related]
17. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
[TBL] [Abstract][Full Text] [Related]
18. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
Lozano-Rodríguez R; Valentín-Quiroga J; Avendaño-Ortiz J; Martín-Quirós A; Pascual-Iglesias A; Terrón-Arcos V; Montalbán-Hernández K; Casalvilla-Dueñas JC; Bergón-Gutiérrez M; Alcamí J; García-Pérez J; Cascajero A; García-Garrido MÁ; Balzo-Castillo ÁD; Peinado M; Gómez L; Llorente-Fernández I; Martín-Miguel G; Herrero-Benito C; Benito JM; Rallón N; Vela-Olmo C; López-Morejón L; Cubillos-Zapata C; Aguirre LA; Fresno CD; López-Collazo E
Cell Rep; 2022 Jan; 38(2):110235. PubMed ID: 34986327
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment.
Marotz C; Belda-Ferre P; Ali F; Das P; Huang S; Cantrell K; Jiang L; Martino C; Diner RE; Rahman G; McDonald D; Armstrong G; Kodera S; Donato S; Ecklu-Mensah G; Gottel N; Salas Garcia MC; Chiang LY; Salido RA; Shaffer JP; Bryant MK; Sanders K; Humphrey G; Ackermann G; Haiminen N; Beck KL; Kim HC; Carrieri AP; Parida L; Vázquez-Baeza Y; Torriani FJ; Knight R; Gilbert J; Sweeney DA; Allard SM
Microbiome; 2021 Jun; 9(1):132. PubMed ID: 34103074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
